Home

IGOR Y KHANDROS

CIK 1256946 · CEO · last filed 2023-10-03

IGOR Y KHANDROS is a CEO who has filed 24 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for CELL, was dated Oct 3, 2023. Across all open-market trades the lifetime net is −$115.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $243.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$243.81M

Companies

3

Total Filings

24

Lifetime Open-Market Net

-$115.74M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Bruker Cellular Analysis, Inc. (CELL) Delisted Director 8,819,993 $1.00 $8.80M $0 2 2023-10-03
Bruker Cellular Analysis, Inc. (BLI) Delisted Director 18,025,277 $1.20 $21.63M -$110.74M 10 2022-08-01
FORM CEO 2,309,499 $105.57 $243.81M -$5.00M 12 2008-04-04

Recent Filings

24 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-10-03 Bruker Cellular Analysis, Inc. (CELL) Delisted Mixed −8,889,993 $0 EDGAR
2023-06-01 Bruker Cellular Analysis, Inc. (CELL) Delisted Grant (A) +70,000 $0 EDGAR
2022-08-01 Bruker Cellular Analysis, Inc. (BLI) Delisted Grant (A) +19,565 $0 EDGAR
2021-09-09 Bruker Cellular Analysis, Inc. (BLI) Delisted Sell (S) −75,000 -$2.75M EDGAR
2021-09-02 Bruker Cellular Analysis, Inc. (BLI) Delisted Sell (S) −75,000 -$2.67M EDGAR
2021-08-26 Bruker Cellular Analysis, Inc. (BLI) Delisted Sell (S) −75,000 -$2.64M EDGAR
2021-08-23 Bruker Cellular Analysis, Inc. (BLI) Delisted Sell (S) −37,500 -$1.33M EDGAR
2021-08-17 Bruker Cellular Analysis, Inc. (BLI) Delisted Sell (S) −37,500 -$1.51M EDGAR
2021-05-18 Bruker Cellular Analysis, Inc. (BLI) Delisted Grant (A) +1,400 $0 EDGAR
2020-12-18 Bruker Cellular Analysis, Inc. (BLI) Delisted Sell (S) −159,692 -$13.18M EDGAR
Showing 1–10 of 24
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.